Verrica Pharmaceuticals Inc (VRCA)
0.9945
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
+0.01
(+0.55%)
After-Hours: 20:00
Verrica Pharmaceuticals Shareholders Equity (Quarterly): -34.05M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -34.05M |
| June 30, 2024 | -13.30M |
| March 31, 2024 | 1.508M |
| December 31, 2023 | 19.76M |
| September 30, 2023 | 42.30M |
| June 30, 2023 | 55.40M |
| March 31, 2023 | 64.85M |
| December 31, 2022 | 40.03M |
| September 30, 2022 | 44.76M |
| June 30, 2022 | 16.33M |
| March 31, 2022 | 25.42M |
| December 31, 2021 | 32.60M |
| September 30, 2021 | 40.85M |
| June 30, 2021 | 52.16M |
| Date | Value |
|---|---|
| March 31, 2021 | 61.81M |
| December 31, 2020 | 32.99M |
| September 30, 2020 | 39.18M |
| June 30, 2020 | 48.46M |
| March 31, 2020 | 56.61M |
| December 31, 2019 | 65.02M |
| September 30, 2019 | 71.65M |
| June 30, 2019 | 76.84M |
| March 31, 2019 | 82.76M |
| December 31, 2018 | 89.43M |
| September 30, 2018 | 96.35M |
| June 30, 2018 | 101.59M |
| March 31, 2018 | 27.75M |
| December 31, 2017 | -7.041M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-34.05M
Minimum
Sep 2024
65.02M
Maximum
Dec 2019
34.63M
Average
40.44M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Elite Pharmaceuticals Inc | 47.27M |
| Eagle Pharmaceuticals Inc | 252.04M |
| TELA Bio Inc | -6.272M |
| Terns Pharmaceuticals Inc | 364.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.93M |
| Total Liabilities (Quarterly) | 66.98M |
| Debt to Equity Ratio | -1.272 |
| Current Ratio | 1.341 |
| Net Debt Paydown Yield | -13.10% |